Meeting
2016 ASCO Annual Meeting
HER2 gene amplification testing by fluorescence in situ hybridization (FISH): Comparison of the ASCO-CAP guidelines with FISH scores used for enrollment in breast cancer international research group (BCIRG) clinical trials.
Authors
Michael F. Press
University of Southern California, Los Angeles, CA
Michael F. Press , Guido Sauter , Marc E. Buyse , Hélène Fourmanoir , Emmanuel Quinaux , Denice D. Tsao-Wei , Wolfgang Eiermann , Nicholas J. Robert , Tadeusz Pienkowski , John Crown , Miguel Martin , Vicente Valero , John Robert Mackey , Valerie Bee-Munteanu , Yanling Ma , Ivonne Villalobos , Anaamika Campeau , Martina Mirlacher , Mary-Ann Lindsay , Dennis J. Slamon
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Discussion Session
Session Title
Breast Cancer—HER2/ER
Track
Breast Cancer
Sub Track
HER2+
Citation
J Clin Oncol 34, 2016 (suppl; abstr 515)
DOI
10.1200/JCO.2016.34.15_suppl.515
Abstract #
515
Poster Bd #
3
Abstract Disclosures
Similar Posters
First Author: Katherine Geiersbach
Poster
2017 ASCO-SITC Clinical Immuno-Oncology Symposium
HER2 gene amplification and protein overexpression in uterine clear cell carcinoma and its implications in targeted immunotherapy.
First Author: Jain Zhou
Poster
2014 ASCO Annual Meeting
Concordance study of HER2 fluorescence in situ hybridization (FISH) assays in upper gastrointestinal (UGI) adenocarcinomas.
First Author: Michael F. Press
Poster
2012 ASCO Annual Meeting
Assessment of HER2 gene amplification in adenocarcinomas of the stomach or gastroesophageal junction in the INT-0116/SWOG9008 clinical trial.
First Author: Michael Alexander Gordon